Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CRVS	CORVUS PHARMACEUTICALS INC	$1.19B	-23.30%	-20.30%	-24.75%	-25.20%	0.16	6.21	N/A	N/A	N/A
ATAI	ATAIBECKLEY INC	$1.29B	-389.70%	-287.70%	-244.61%	-421.50%	0.32	11.74	100.00%	-16,142.00%	-16,106.31%
EDSA	EDESA BIOTECH INC	$54.85M	-55.80%	-52.50%	-56.01%	3,171.80%	0.05	16.82	N/A	N/A	N/A
HUMA	HUMACYTE INC	$154.12M	N/A	-27.90%	-39.90%	-24.80%	-20.26	1.62	60.50%	-2,353.20%	-1,674.35%
VERU	VERU INC	$36.76M	-83.20%	-55.60%	-47.26%	-659.20%	0.28	5.16	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.72B	-67.50%	-54.60%	-31.86%	-124.80%	0.16	9.01	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$2.12B	-24.20%	-23.40%	-22.56%	-32.10%	0.04	28.66	N/A	N/A	N/A
ALGS	ALIGOS THERAPEUTICS INC	$43.07M	-28.20%	-20.00%	-41.31%	-40.60%	0.65	3.90	100.00%	-1,106.70%	-1,271.77%
PRME	PRIME MEDICINE INC	$655.40M	-178.60%	-60.30%	-65.89%	-60.30%	1.84	4.84	100.00%	-4,342.40%	-4,342.44%
GHRS	GH RESEARCH PLC	$846.70M	-16.30%	-15.80%	-17.08%	-99.00%	0.03	34.13	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$1.58B	-40.70%	-36.00%	-35.01%	-130.70%	0.12	15.50	N/A	N/A	N/A
KYNB	KYNTRA BIO INC	$27.48M	-150.70%	122.30%	212.64%	160.20%	-3.83	3.39	91.40%	2,848.60%	2,983.25%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$740.30M	-85.90%	-41.90%	-32.43%	-143.60%	0.09	12.34	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$3.54B	-38.80%	-36.40%	-32.46%	-41.50%	0.08	13.32	100.00%	-7,973.30%	-7,973.33%
PDSB	PDS BIOTECHNOLOGY CORP	$31.10M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A
NUVL	NUVALENT INC	$7.70B	-42.10%	-37.50%	-32.14%	-47.40%	0.13	15.27	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$495.82M	-30.10%	-28.30%	-22.47%	-35.30%	0.06	27.50	N/A	N/A	N/A
IMNM	IMMUNOME INC	$2.30B	-57.60%	-52.40%	-33.28%	-472.30%	0.08	14.69	100.00%	-3,060.00%	-3,059.99%
SVRA	SAVARA INC	$1.08B	-84.00%	-63.60%	-50.99%	-66.30%	0.25	11.85	N/A	N/A	N/A
SXTP	60 DEGREES PHARMACEUTICALS INC	$1.64M	-225.80%	-149.90%	-177.30%	-780.20%	0.53	2.87	22.40%	-688.20%	-647.06%
ACTU	ACTUATE THERAPEUTICS INC	$53.92M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
ABSI	ABSCI CORP	$446.82M	-59.70%	-51.00%	-59.37%	-94.50%	0.14	6.57	100.00%	-4,113.70%	-4,103.75%
MLEC	MOOLEC SCIENCE SA	$4.84M	-40.70%	-13.90%	-5.94%	-12.60%	1.77	0.91	38.80%	-16.50%	-7.55%
XNCR	XENCOR INC	$909.40M	-14.60%	-10.40%	-7.37%	-6.10%	0.38	6.25	100.00%	-73.20%	-45.78%
INTS	INTENSITY THERAPEUTICS INC	$15.33M	-370.90%	-214.60%	-160.57%	-7,289.40%	0.33	3.60	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$660.31M	-48.20%	-38.20%	-35.05%	-237.80%	0.22	15.69	N/A	N/A	N/A
NBY	NOVABAY PHARMACEUTICALS INC	$37.81M	N/A	-302.20%	-280.51%	-6,614.20%	-1.38	7.60	N/A	N/A	N/A
CING	CINGULATE INC	$73.96M	-515.30%	-174.30%	-471.57%	-717.00%	5.01	1.16	N/A	N/A	N/A
IMUX	IMMUNIC INC	$172.21M	-1,197.80%	-265.00%	1,479.93%	449.40%	-4.60	0.75	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$533.23M	-83.90%	-67.60%	-66.79%	430.70%	0.12	9.05	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$621.35M	-57.30%	-42.40%	-44.90%	-44.40%	0.37	7.45	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$147.39M	-65.80%	-57.90%	-53.24%	-80.20%	0.14	8.07	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$73.06M	-59.10%	-54.20%	-76.00%	-88.10%	0.11	10.09	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$194.63M	15.20%	12.50%	8.34%	15.10%	0.14	9.46	N/A	N/A	N/A
IFRX	INFLARX NV	$67.96M	-85.10%	-65.00%	-107.93%	-133.40%	0.33	4.13	-24,677.90%	-155,582.10%	-155,410.08%
TERN	TERNS PHARMACEUTICALS INC	$4.76B	-30.00%	-28.50%	-32.91%	-55.60%	0.06	19.52	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$372.40M	-38.90%	-37.70%	-23.66%	4,739.40%	0.02	67.69	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$98.45M	-755.20%	-188.30%	-478.42%	2,290.60%	129.93	1.84	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$3.13B	-61.50%	-50.90%	-38.72%	-132.70%	0.22	22.25	N/A	N/A	N/A
FBRX	FORTE BIOSCIENCES INC	$330.46M	-75.60%	-65.90%	-61.53%	-3,473.20%	0.15	7.34	N/A	N/A	N/A
MGX	METAGENOMI THERAPEUTICS INC	$52.29M	-47.10%	-33.80%	-44.37%	-37.70%	0.39	7.22	100.00%	-348.50%	-348.77%
NKTX	NKARTA INC	$151.29M	-27.70%	-22.20%	-25.13%	-21.80%	0.26	15.24	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.81B	-71.70%	-51.20%	-33.56%	-272.30%	0.24	15.39	87.30%	-511.90%	-489.12%
HOTH	HOTH THERAPEUTICS INC	$13.95M	-133.70%	-123.40%	-147.77%	-3,822.00%	0.12	8.81	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$165.68M	N/A	-35.50%	-49.56%	-84.30%	-3.35	8.66	100.00%	-4,658.60%	-4,987.31%
ATRA	ATARA BIOTHERAPEUTICS INC	$40.56M	-79.10%	87.60%	687.20%	61.10%	-1.53	0.82	82.40%	27.10%	30.23%
IMMX	IMMIX BIOPHARMA INC	$299.18M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$34.12M	-336.90%	-184.40%	-316.68%	1,845.00%	1.34	1.76	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$31.27M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
APGE	APOGEE THERAPEUTICS INC	$5.46B	-36.80%	-34.90%	-28.11%	-43.00%	0.04	26.57	N/A	N/A	N/A
CLNN	CLENE INC	$64.55M	N/A	-119.10%	-319.39%	-89.70%	-2.03	0.83	78.50%	-13,086.50%	-11,745.50%
ANNX	ANNEXON INC	$641.83M	-93.10%	-72.90%	-111.57%	-120.40%	0.42	4.43	N/A	N/A	N/A
KROS	KEROS THERAPEUTICS INC	$223.60M	14.30%	13.30%	28.93%	207.50%	0.12	15.45	100.00%	35.70%	37.65%
REPL	REPLIMUNE GROUP INC	$624.25M	-102.70%	-72.20%	-108.40%	-88.80%	0.58	5.60	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.38B	-28.90%	-27.30%	-22.60%	-37.00%	0.06	26.17	N/A	N/A	N/A
ALEC	ALECTOR INC	$239.49M	-225.00%	-41.00%	-63.81%	-58.80%	8.57	3.83	100.00%	-679.20%	-678.36%
SPRB	SPRUCE BIOSCIENCES INC	$96.00M	-204.00%	-128.00%	-90.55%	862.60%	0.25	5.17	N/A	N/A	N/A
OMER	OMEROS CORP	$740.20M	N/A	-53.90%	-121.65%	-23.80%	-1.84	0.89	N/A	N/A	N/A
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$4.77M	-20,541.50%	-187.50%	-494.36%	222.10%	2.15	1.39	N/A	N/A	N/A
TIL	INSTIL BIO INC	$58.32M	-53.00%	-31.80%	-32.91%	-22.50%	0.76	34.45	N/A	N/A	N/A
QSI	QUANTUM-SI INC	$187.16M	-43.90%	-39.30%	-45.50%	-46.60%	0.12	7.64	47.30%	-4,160.10%	-4,157.68%
KYMR	KYMERA THERAPEUTICS INC	$6.44B	-29.10%	-25.40%	-18.74%	-31.00%	0.10	10.47	100.00%	-794.00%	-793.10%
PGEN	PRECIGEN INC	$1.10B	-5,766.20%	-311.30%	-176.76%	-238.60%	3.09	4.04	30.30%	-6,750.10%	-3,899.94%
PRAX	PRAXIS PRECISION MEDICINES INC	$8.69B	-58.70%	-53.50%	-34.54%	-98.00%	0.07	10.22	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$417.72M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$13.29M	N/A	-158.30%	-219.75%	808.30%	0.47	1.41	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$357.25M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$11.25M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$5.92B	-100.20%	-68.50%	-37.30%	-94.90%	0.47	14.24	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$1.45B	-62.60%	-50.10%	-49.35%	-114.00%	0.20	5.96	100.00%	-8,253.30%	-8,199.34%
PASG	PASSAGE BIO INC	$22.76M	-135.00%	-60.40%	-116.13%	-188.10%	2.32	2.07	N/A	N/A	N/A
CRSP	CRISPR THERAPEUTICS AG	$4.52B	-31.50%	-26.70%	-27.31%	-29.00%	0.18	13.32	100.00%	-16,569.80%	-16,466.24%
MNPR	MONOPAR THERAPEUTICS	$380.57M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A
DFTX	DEFINIUM THERAPEUTICS INC	$1.84B	-84.40%	-60.40%	-47.75%	-103.80%	0.32	6.29	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$221.49M	-64.90%	-30.20%	-30.25%	-35.60%	0.40	7.40	N/A	N/A	N/A
TECX	TECTONIC THERAPEUTIC INC	$583.20M	-26.90%	-25.80%	-28.98%	3,727.70%	0.04	26.63	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$134.95M	-60.20%	-52.40%	-71.16%	-63.30%	0.19	8.61	N/A	N/A	N/A
GNPX	GENPREX INC	$4.40M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$4.62B	-55.80%	-52.00%	-58.32%	-69.30%	0.09	13.42	100.00%	-4,612.10%	-4,598.59%
ARMP	ARMATA PHARMACEUTICALS INC	$312.80M	N/A	-54.50%	63.18%	-29.50%	-1.94	0.12	100.00%	-3,797.70%	-2,580.16%
ENTX	ENTERA BIO LTD	$54.11M	-71.90%	-63.40%	-67.99%	2,206.40%	0.14	10.83	0.00%	-8,694.40%	-8,683.06%
BNTX	BIONTECH SE	$21.30B	-6.00%	-5.30%	-4.94%	-11.00%	0.14	7.54	77.60%	-39.60%	-34.18%
BCTX	BRIACELL THERAPEUTICS CORP	$29.36M	-174.50%	-140.80%	-99.17%	-849.10%	0.11	10.10	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$333.42M	-33.40%	-32.20%	-37.23%	-39.40%	0.05	15.16	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$432.62M	-46.30%	-42.50%	-59.73%	-65.00%	0.14	7.82	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$245.32M	-47.00%	-44.10%	-59.73%	1,838.70%	0.13	8.52	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$5.22B	-145.90%	-96.70%	-106.36%	-188.30%	0.65	6.95	N/A	N/A	N/A
RADX	RADIOPHARM THERANOSTICS LTD	$30.72M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
KOD	KODIAK SCIENCES INC	$1.21B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.56B	-50.10%	-44.20%	-48.97%	-52.00%	0.13	9.16	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$718.19M	-23.20%	-14.00%	-19.18%	-29.00%	0.53	3.09	100.00%	-26.70%	-26.42%
SANA	SANA BIOTECHNOLOGY INC	$827.29M	-142.00%	-58.90%	-72.20%	-148.50%	1.59	1.89	N/A	N/A	N/A
MSLE	SATELLOS BIOSCIENCE INC	$104.61M	N/A	N/A	N/A	N/A	0.07	14.84	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$87.62M	13.30%	3.90%	4.79%	3.80%	2.13	2.56	100.00%	721.90%	721.93%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$367.73M	-69.20%	-66.80%	-47.92%	-20,841.50%	0.07	15.12	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$1.02B	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
NGNE	NEUROGENE INC	$343.10M	-33.00%	-30.40%	-33.19%	-41.80%	0.09	16.56	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$18.69B	-63.10%	-48.10%	-53.63%	-53.70%	0.44	7.15	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$56.43k	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
VRDN	VIRIDIAN THERAPEUTICS INC	$2.90B	-58.40%	-50.40%	-40.74%	-66.10%	0.25	12.65	100.00%	-483.60%	-476.58%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.